Gruss Lipper Biophotonics Center

Overview

The Gruss Lipper Biophotonics Center (GLBC) of Albert Einstein College of Medicine of Yeshiva University is a premier research facility dedicated to advanced biomedical research. Located at the Jack and Pearl Resnick Campus, the center mandates are to: study and develop novel microscopy techniques that answer fundamental biological questions leading to cures for biomedical problems; make advanced and novel microscopy technologies, methods and reagents available to the research community; and support the education and training of postdoctoral fellows and graduate students in advanced biophotonics techniques.

Codirected by Drs. John Condeelis and Robert Singer, the GLBC was established through the generosity of the Gruss Lipper Family Foundation.


 

In The News

WABC-TV interviews Dr. John Condeelis about his imaging research that is helping to explain how cancer spreads from the primary tumor. (Monday, Oct 06, 2014)

Nature highlights research by Dr. John Condeelis that uses intravital imaging to reveal how breast cancer cells spread from the primary tumor. (Thursday, May 08, 2014)

The Scientist interviews Dr. Robert Singer regarding his new research finding that genes which create "housekeeping" proteins turn on and off randomly, not in a coordinated way, as previously thought. (Tuesday, Dec 07, 2010)

The New York Times, Science Times, interviews Dr. John S. Condeelis on Einstein research into technologies that allow scientists to watch cells, including cancer cells, move. (Monday, Jun 08, 2009)

Los Angeles Times features comments by Dr. John Condeelis on the first marker that could reliably predict metastatic breast cancer. (Tuesday, Mar 24, 2009)

NCI Cancer Bulletin interviews Dr. John Condeelis about advanced imaging techniques developed by researchers in Einstein's Gruss Lipper Biophotonics Center that allows cancer cells to be viewed for weeks. (Tuesday, Jan 27, 2009)

Washington Post, U.S. News & World Report, and others report on a new protein marker for metastatic breast cancer. The marker, detailed in a study published in Developmental Cell, was discovered by Einstein and MIT researchers. The Einstein team was lead by Dr. John Condeelis, co-chair of anatomy and structural biology. (Monday, Dec 08, 2008)

Reuters interviews Dr. Jeffrey Segall, professor of anatomy and structural biology, on a novel method of viewing cancer cells over several days. The article, entitled "Glass implant on tumor helps track cancer in mice," is based on a study published by Nature Methods under the direction of Dr. Segall and John Condeelis, Ph.D., co-chair and professor of anatomy and structural biology and co-director of the Gruss Lipper Biophotonics Center. (Sunday, Nov 09, 2008)

media coverage on other stories

Click here to log in